AMWL
American Well CorporationNYSEHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.39
P/S
0.37
EV/EBITDA
1.20
DCF Value
$-95.69
FCF Yield
-71.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
53.3%
Operating Margin
-42.2%
Net Margin
-38.4%
ROE
-35.9%
ROA
-29.6%
ROIC
-41.4%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $55.3M | $-24.9M | $-1.52 |
| FY 2025 | $249.3M | $-95.7M | $-5.96 |
| Q3 2025 | $56.3M | $-32.4M | $-2.00 |
| Q2 2025 | $70.9M | $-19.7M | $-1.24 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NYSE
Beta
1.39
American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.